Form 4: Cardlytics Director Liane Hornsey Reports Stock Transaction
SEC Form 4 Filing
Director Liane Hornsey reports the vesting of restricted stock units into Cardlytics common stock.
Summary
- On April 9, 2025, Liane Hornsey, a director of Cardlytics, Inc., reported a transaction involving restricted stock units (RSUs).
- The transaction involved the vesting of 1,326 RSUs, which converted into 1,326 shares of Cardlytics common stock.
- Following the transaction, Hornsey directly owns 11,326 shares of Cardlytics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on a standard stock transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 04/09/2024 | Grant date of the restricted stock unit award for 1,326 shares. |
| 04/09/2025 | Date of transaction: vesting of 1,326 restricted stock units and report filing date. |
Keywords
Cardlytics, Director, Hornsey, Stock, RSU, CDLX, Transaction, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.